Herzschrittmachertherapie & Elektrophysiologie
[What to do with device-detected atrial fibrillation? : Executive summary of the position paper of the German Society of Cardiology].
Tobias Tönnis, Nina Becher, Ralf Birkemeyer, David Duncker, Lars Eckardt, Klaus Gröschel, Dominik Linz, Christian Meyer, Florian Straube, Arian Sultan, Rolf Wachter, Maura Zylla, Paulus Kirchhof
Published: 202510.1007/s00399-025-01112-7
Abstract
Device-detected atrial fibrillation (DDAF), like clinical atrial fibrillation (AF), is also associated with an increased risk of thromboembolic events, although the risk appears to be significantly lower. The efficacy and safety of oral anticoagulati…
Preview only. Read the full abstract at the source